valerylsalicylate has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 9 studies
Studies (valerylsalicylate) | Trials (valerylsalicylate) | Recent Studies (post-2010) (valerylsalicylate) | Studies (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) | Trials (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) | Recent Studies (post-2010) (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide) |
---|---|---|---|---|---|
24 | 0 | 5 | 1,220 | 3 | 229 |
Protein | Taxonomy | valerylsalicylate (IC50) | n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide (IC50) |
---|---|---|---|
Prostaglandin E synthase | Homo sapiens (human) | 10 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 2.1 | |
Aromatase | Homo sapiens (human) | 0.68 | |
Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | 1.67 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 3 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.9037 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4333 | |
Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.1522 | |
Carboxypeptidase B2 | Homo sapiens (human) | 1.8 | |
Prostaglandin E synthase | Mus musculus (house mouse) | 0.007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaminski, DL; Longo, WE; Mazuski, J; Panesar, N | 1 |
Briggs, JP; Schnermann, J; Smart, A; Traynor, TR | 1 |
Davidson, ME; Lang, RJ | 1 |
Eriksson, E; Hellstrand, M; Nilsson, CL | 1 |
Calixto, JB; El Sayah, M | 1 |
Fortier, MA; Parent, J; Villeneuve, C | 1 |
Bratz, IN; Kanagy, NL | 1 |
Feletou, M; Gluais, P; Lonchampt, M; Morrow, JD; Vanhoutte, PM | 1 |
Huang, A; Jacobson, A; Kaley, G; Liu, H; Ojaimi, C; Sun, D; Yan, C | 1 |
9 other study(ies) available for valerylsalicylate and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Article | Year |
---|---|
Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
Topics: Calcimycin; Calcium; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Eicosanoids; Epithelial Cells; Humans; Immunoblotting; Interleukin-1; Intestinal Mucosa; Isoenzymes; Lipopolysaccharides; Membrane Proteins; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Salicylates; Sulfonamides; Tetradecanoylphorbol Acetate | 1998 |
Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; In Vitro Techniques; Isoenzymes; Juxtaglomerular Apparatus; Kidney Tubules, Distal; Nitrobenzenes; Osmolar Concentration; Prostaglandin-Endoperoxide Synthases; Rabbits; Renin; Salicylates; Sodium Chloride; Sulfonamides | 1999 |
Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Guinea Pigs; Indomethacin; Isoenzymes; Kidney Pelvis; Male; Membrane Proteins; Muscle Contraction; Muscle, Smooth; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Salicylates; Sulfonamides; Ureter | 2000 |
Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent.
Topics: Animals; Arachidonic Acids; Calcium; Calcium Channel Blockers; CHO Cells; Cricetinae; Cyclooxygenase 2; Dinoprostone; Dopamine; Dopamine Antagonists; Drug Interactions; Enzyme Inhibitors; Gallic Acid; Indomethacin; Isoenzymes; Naphthalenes; Nitrobenzenes; Phosphatidylcholines; Prostaglandin-Endoperoxide Synthases; Pyrones; Quinacrine; Receptors, Dopamine D2; Salicylamides; Salicylates; Sulfonamides; Tetradecanoylphorbol Acetate; Transfection | 2002 |
Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro.
Topics: Animals; Atropine; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanethidine; Ibuprofen; Imidazoles; In Vitro Techniques; Indomethacin; Iris; Kallidin; Muscle Contraction; Muscle, Smooth; Nitrobenzenes; Propionates; Quinolines; Salicylates; Sulfonamides; Swine; Tetrodotoxin; Thromboxane-A Synthase | 2003 |
Evaluation of the contribution of cyclooxygenase 1 and cyclooxygenase 2 to the production of PGE2 and PGF2 alpha in epithelial cells from bovine endometrium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Blotting, Western; Cattle; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Dinoprostone; Endometrium; Epithelial Cells; Female; Flurbiprofen; Isoenzymes; Nitrobenzenes; Oxytocin; Prostaglandin-Endoperoxide Synthases; Salicylates; Stimulation, Chemical; Sulfonamides | 2003 |
Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function.
Topics: Adrenergic alpha-Agonists; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Isoenzymes; Male; Membrane Proteins; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Nitrobenzenes; Norepinephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Salicylates; Sulfonamides; Vasoconstriction | 2004 |
Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta, Thoracic; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Imidazoles; In Vitro Techniques; Indomethacin; Nitrobenzenes; Prostaglandins; Prostaglandins I; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Salicylates; Sulfonamides; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2005 |
COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.
Topics: Animals; Arterioles; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Membrane Proteins; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandins; Regional Blood Flow; Salicylates; Sulfonamides; Vasodilation | 2006 |